Serum concentrations of MIF and NGAL.

<p>Concentration of (A) serum MIF and (B) serum NGAL at 4 different time points: baseline (BL; under anesthesia before skin incision), day 0 (at the end of surgery), day 1 (24 hours after graft reperfusion on day 1 after OLT), and on day 2 (48 hours after reperfusion on day 2 after OLT). White bars indicate values of patients with no AKI or stage 1 AKI, gray bars represent values of patients who developed stage 2 or 3 AKI after undergoing OLT. P values indicate significant differences between groups.</p

Area under the ROC curve for development of severe AKI.

<p>Area under the ROC curve for development of severe AKI.</p

Demographic data of the study population.

<p>Demographic data of the study population.</p

Receiver operating characteristic (ROC) curves of MIF and NGAL for predicting severe AKI after OLT.

<p>(A) ROC curves of serum MIF (sMIF, solid line) and serum NGAL (sNGAL, dashed line) at day 0, day 1 and day 2 after OLT. (B) ROC curves of urinary MIF (uMIF, solid line) and urinary NGAL (uNGAL, dashed line) at day 0, day 1 and day 2 after OLT.</p

Area under the ROC curve for development of any stage of AKI.

<p>Area under the ROC curve for development of any stage of AKI.</p